Zdrowie i gospodarka · 24/07/2012
FDA Offers Opportunity to Affirm Outstanding Hearing Requests for Certain Prescription Drugs
The Food and Drug Administration (FDA) is giving companies a chance to confirm their interest in pursuing outstanding hearing requests for several prescription drugs, warning that failing to respond may result in request withdrawal.